2023
DOI: 10.1080/10837450.2023.2193254
|View full text |Cite
|
Sign up to set email alerts
|

Newly developed nano-biocomposite embedded hydrogel to enhance drug loading and modulated release of anti-inflammatory drug

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 38 publications
0
3
0
Order By: Relevance
“…Therefore, films with higher amounts of nanocomposite exhibit lower swelling ratios. Varghese et al have observed a similar reduction in swelling ratio and disruption of polymeric chains on the addition of the iron-based nano biocomposite to the alginate matrix …”
Section: Resultsmentioning
confidence: 74%
See 1 more Smart Citation
“…Therefore, films with higher amounts of nanocomposite exhibit lower swelling ratios. Varghese et al have observed a similar reduction in swelling ratio and disruption of polymeric chains on the addition of the iron-based nano biocomposite to the alginate matrix …”
Section: Resultsmentioning
confidence: 74%
“…A higher drug release from the TCl film can be attributed to its inherent hydrophilicity. However, the drug release from the matrix of the modified films decreased due to the reduction in hydrophilicity and swelling ratio . This implies that reduced water ingress into the SA film matrix affects the drug release.…”
Section: Resultsmentioning
confidence: 99%
“… 174 , 175 Iron-based nano-biocomposite impregnated alginate formulation and ferulic acid-derived lignin nanoparticle disintegrate at colon pH, which achieves the delivery of targeting colon. 176 , 177 Curcumin, decorated with a prussian blue analog can be released in inflammatory tissue (acidic environment), which promotes the polarization of M2 macrophages and the clearance of ROS. 178 A mesoporous polydopamine-derived nanomedicine loading polyacrylic acid releases Sulfasalazine at the inflammatory site of colon to scavenge excessive ROS.…”
Section: Ibd Treatments: Based On Experimentsmentioning
confidence: 99%